Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-13 5:27:38 am | Coya Therapeutics In Catbird Seat Following Dr. Reddy's Licensing Deal | SeekingAlpha |
| 2024-02-05 6:50:7 am | Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term | Zacks |
| 2024-02-02 6:45:7 am | Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick | Zacks |
| 2024-02-01 8:1:37 am | Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2024 Earnings Call Transcript | Insider Monkey |
| 2024-02-01 6:3:0 am | Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates | Zacks |
| 2024-01-31 6:44:0 am | Dr. Reddy’s Q3 & 9M FY24 Financial Results | Business Wire |
| 2024-01-30 3:19:54 am | UPDATE 1-Indian pharma firm Dr Reddy's beats Q3 profit view on strong US, European businesses | Reuters |
| 2024-01-30 2:38:36 am | India's Dr Reddy's beats Q3 profit estimates on strong US sales | Reuters |
| 2024-01-03 3:0:0 am | Dr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women’s Health and Dietary Supplements Portfolio of Brands | Business Wire |
Please consider a small donation if you think this website provides you with relevant information